Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
Details for Australian Patent Application No. 2005297795 (hide)
International Classifications
Event Publications
7 June 2007 PCT application entered the National Phase
PCT publication WO2006/046774 Priority application(s): WO2006/046774
3 January 2008 Alteration of Name
The name of the applicant has been altered to Mitsubishi Tanabe Pharma Corporation 2006
12 March 2009 Application Accepted
Published as AU-B-2005297795
9 July 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005297799-3-carbamoyl-2-pyridone derivative
2005297772-Anti-glypican 3 antibody having modified sugar chain
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser